Cannabliss And Canadian Bioceutical Corp. Sign Cooperation Agreement

March 18, 2015 | The Canadian Bioceutical Corporation’s subsidiary BioCannabis Products announced that it entered into an agreement with Tel Aviv-based company Cannabliss. According to the agreement, the two companies will cooperate on the conception, research, development and production of cannabis-related medicinal products and technologies with the eventual goal of consummating licensing and distribution agreements for the Canadian medical marijuana market. Cannabliss is an Israeli company specializing in development, manufacturing and marketing of high-end standardized medical cannabis-based products, under a license from the Ministry of Health since 2009.